These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 37296644)

  • 1. Current State and Future Directions in the Therapy of ALS.
    Tzeplaeff L; Wilfling S; Requardt MV; Herdick M
    Cells; 2023 May; 12(11):. PubMed ID: 37296644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents.
    Johnson SA; Fang T; De Marchi F; Neel D; Van Weehaeghe D; Berry JD; Paganoni S
    Drugs; 2022 Sep; 82(13):1367-1388. PubMed ID: 36121612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic news in ALS.
    Corcia P; Beltran S; Bakkouche SE; Couratier P
    Rev Neurol (Paris); 2021 May; 177(5):544-549. PubMed ID: 33781562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?
    Xu X; Shen D; Gao Y; Zhou Q; Ni Y; Meng H; Shi H; Le W; Chen S; Chen S
    Transl Neurodegener; 2021 Aug; 10(1):29. PubMed ID: 34372914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.
    Talman P; Duong T; Vucic S; Mathers S; Venkatesh S; Henderson R; Rowe D; Schultz D; Edis R; Needham M; Macdonnell R; McCombe P; Birks C; Kiernan M
    BMJ Open; 2016 Sep; 6(9):e012054. PubMed ID: 27694488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyotrophic Lateral Sclerosis: Autoimmune Pathogenic Mechanisms, Clinical Features, and Therapeutic Perspectives.
    Ralli M; Lambiase A; Artico M; de Vincentiis M; Greco A
    Isr Med Assoc J; 2019 Jul; 21(7):438-443. PubMed ID: 31507117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hastening the Diagnosis of Amyotrophic Lateral Sclerosis.
    Mitsumoto H; Kasarskis EJ; Simmons Z
    Neurology; 2022 Jul; 99(2):60-68. PubMed ID: 35577578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
    Conde B; Winck JC; Azevedo LF
    Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs.
    Jaiswal MK
    Med Res Rev; 2019 Mar; 39(2):733-748. PubMed ID: 30101496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic development in amyotrophic lateral sclerosis.
    Bucchia M; Ramirez A; Parente V; Simone C; Nizzardo M; Magri F; Dametti S; Corti S
    Clin Ther; 2015 Mar; 37(3):668-80. PubMed ID: 25666449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis.
    Vidovic M; Müschen LH; Brakemeier S; Machetanz G; Naumann M; Castro-Gomez S
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis.
    Sun Y; Li X; Bedlack R
    Expert Rev Neurother; 2023 Jan; 23(1):1-7. PubMed ID: 36705941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of stem cells therapy in amyotrophic lateral sclerosis.
    Je G; Keyhanian K; Ghasemi M
    Neurol Res; 2021 Aug; 43(8):616-632. PubMed ID: 33632084
    [No Abstract]   [Full Text] [Related]  

  • 15. [Familial Amyotrophic Lateral Sclerosis].
    Suzuki N; Nishiyama A; Kato M; Warita H; Aoki M
    Brain Nerve; 2019 Nov; 71(11):1169-1181. PubMed ID: 31722303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis.
    Elmansy MF; Reidl CT; Rahaman M; Özdinler PH; Silverman RB
    Med Res Rev; 2023 Nov; 43(6):2260-2302. PubMed ID: 37243319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-modifying therapies in amyotrophic lateral sclerosis.
    Chiò A; Mazzini L; Mora G
    Neuropharmacology; 2020 May; 167():107986. PubMed ID: 32062193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis.
    Maranzano A; Verde F; Colombo E; Poletti B; Doretti A; Bonetti R; Gagliardi D; Meneri M; Maderna L; Messina S; Corti S; Morelli C; Silani V; Ticozzi N
    Brain; 2023 Oct; 146(10):4105-4116. PubMed ID: 37075222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis.
    Sever B; Ciftci H; DeMirci H; Sever H; Ocak F; Yulug B; Tateishi H; Tateishi T; Otsuka M; Fujita M; Başak AN
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis.
    Hodgkinson VL; Lounsberry J; Mirian A; Genge A; Benstead T; Briemberg H; Grant I; Hader W; Johnston WS; Kalra S; Linassi G; Massie R; Melanson M; O'Connell C; Schellenberg K; Shoesmith C; Taylor S; Worley S; Zinman L; Korngut L
    Can J Neurol Sci; 2018 Nov; 45(6):652-659. PubMed ID: 30430962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.